Effects of propofol on the development of cancer in humans

Citations Over TimeTop 1% of 2020 papers

Abstract

Cancer is one of most the significant threats to human health worldwide, and the primary method of treating solid tumours is surgery. Propofol, one of the most widely used intravenous anaesthetics in surgery, was found to be involved in many cancer-related pathophysiology processes, mainly including anti-tumour and minor cancer-promoting effects in various types of cancer. An increasing number of studies have identified that propofol plays a role in cancer by regulating the expression of multiple signalling pathways, downstream molecules, microRNAs and long non-coding RNAs. Emerging evidence has indicated that propofol can enhance the anti-tumour effect of chemotherapeutic drugs or some small molecular compounds. Additionally, in vivo animal models have shown that propofol inhibits tumour growth and metastasis. Furthermore, most clinical trials indicate that propofol is associated with better survival outcomes in cancer patients after surgery. Propofol use is encouraged in cancers that appear to have a better prognosis after its use during surgery. We hope that future large and prospective multicenter studies will provide more precise answers to guide the choice of anaesthetics during cancer surgery.

Related Papers

• → Comparative Study between Propofol in a Long-chain Triglyceride and Propofol in a Medium/Long-chain Triglyceride during Sedation with Target-controlled Infusion(2005)6 cited
• Relationship between bispectral index(BIS) and propofol blood concentration in patients with different age during target controlled infusion(TCI) of propofol(2007)
• Outcomes of anesthesia with TCI of propofol and remifentanel in the elderly undergoing gestroendoscopy(2013)
• 수면 대장내시경에서 Propofol 단독요법과 Midazolam, Propofol 병합요법의 효과 비교 연구(2006)